SOHO State of the Art Updates and Next Questions: Withdrawal Syndrome after Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI

ConclusionIn total, 42% of the patients experienced WS after TKI therapy discontinuation in the RU-SKI study. Physicians should be warned about the possibility of WS development, and patients of older age and with longer TKI treatment need special attention.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research